BioSerenity
PrivateLast Round
Recap
Nov 13, 2023
Total Funding Raised
$94.1M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
BioSerenity operates in Healthcare & Life Sciences and is based in Paris. Its latest recorded funding round was a Series B round in June 2019.
BioSerenity is a medical technology company that develops connected medical devices and AI-powered digital health solutions for remote patient monitoring in neurology, cardiology, and sleep disorders.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Telemedicine, Medical AI, Health IoT
Business Model
B2B
Customer Profile
Hardware + Subscription, Services & Consulting, Hardware Sales
AI Layer
Foundation
Historical Pricing
Historical view of private secondary pricing and transaction trends.
BioSerenity Comparables
Compare BioSerenity with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Stratus | 84% | |
| Zeto, Inc. | 81% | |
| Seer Medical | 78% |
For institutional investors. Book with your work email.
BioSerenity Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Recap | Nov 13, 2023 | ||||
| Series B | Jun 18, 2019 | ||||
| Series A | Sep 20, 2017 | ||||
| Seed | Jun 8, 2015 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
BioSerenity Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Idinvest Partners | Series A, Series B, Seed |
| Dassault Systèmes | Series B |
| Jolt Capital | Recap |
| LBO France | Series B, Series A |
| Bpifrance | Series A, Series B |
| Kurma Partners | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 1, 2026
New sleep center planned for Auxerre, France in September 2026.
- Jun 24, 2026
Monthly visitors grew 35% MoM, reaching 8.4K.
For institutional investors. Book with your work email.
BioSerenity Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about BioSerenity's valuation, stock price, and market status.
Is BioSerenity a public or private company?
BioSerenity is a private company.
What is the current stock price of BioSerenity?
BioSerenity is a private company, so its shares have no public market price. Caplight tracks BioSerenity's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is BioSerenity worth (valuation)?
Valuation information for BioSerenity is not publicly available.
Can I buy BioSerenity stock?
BioSerenity shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was BioSerenity's last funding round?
BioSerenity's most recent funding round was Recap on November 13, 2023.
Who are the main investors in BioSerenity?
Key investors in BioSerenity include Idinvest Partners, Dassault Systèmes, Jolt Capital, LBO France, Kurma Partners.
Will BioSerenity IPO soon?
No public IPO plans have been announced for BioSerenity.
How can I track BioSerenity secondary market activity?
Caplight tracks bids, offers, and trades in BioSerenity's shares on secondary markets.